PhaseBio Pharmaceuticals Inc
PHASDelisted Dec 21, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001169245
PhaseBio Pharmaceuticals Inc was delisted on Dec 21, 2022; its insiders filed their last Form 4 on May 19, 2023; 39 institutions reported holding it in 13F filings for Q3 2022, worth $3.90M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding PhaseBio Pharmaceuticals Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 5 | 0 | −5 |
| Shares | 557.9K | 0 | −557.9K (−100.0%) |
| Value | $15.6K | $0 | −$15.6K (−100.0%) |
New holders (0)
Institutions that held PhaseBio Pharmaceuticals Inc at the end of Q1 2023 but not at the end of Q4 2022.
None.
Sold out (5)
Institutions that held PhaseBio Pharmaceuticals Inc at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| DAFNA Capital Management LLC | 321,856 | $9.69K |
| Acadian Asset Management LLC | 172,958 | $4.00K |
| Hamilton Lane Advisors LLC | 34,208 | $1.00K |
| IPG Investment Advisors LLC | 28,700 | $864 |
| Barclays PLC | 197 | $6 |